COLORETTI, IRENE
 Distribuzione geografica
Continente #
NA - Nord America 3.332
AS - Asia 1.793
EU - Europa 1.651
SA - Sud America 267
Continente sconosciuto - Info sul continente non disponibili 54
AF - Africa 53
OC - Oceania 10
Totale 7.160
Nazione #
US - Stati Uniti d'America 3.152
IT - Italia 818
SG - Singapore 535
CN - Cina 484
HK - Hong Kong 185
VN - Vietnam 173
BR - Brasile 169
DE - Germania 160
GB - Regno Unito 152
SE - Svezia 96
BD - Bangladesh 92
RU - Federazione Russa 84
CA - Canada 80
FR - Francia 66
KR - Corea 65
FI - Finlandia 53
ID - Indonesia 51
NL - Olanda 46
IN - India 45
MX - Messico 41
AR - Argentina 37
ES - Italia 31
TR - Turchia 26
LT - Lituania 25
IQ - Iraq 24
AT - Austria 16
PK - Pakistan 16
EC - Ecuador 15
BG - Bulgaria 14
CL - Cile 14
AE - Emirati Arabi Uniti 12
PL - Polonia 12
UA - Ucraina 12
CO - Colombia 11
CZ - Repubblica Ceca 11
JP - Giappone 11
AU - Australia 10
CR - Costa Rica 10
IE - Irlanda 10
ZA - Sudafrica 10
BE - Belgio 9
IL - Israele 9
MY - Malesia 8
GT - Guatemala 7
NP - Nepal 7
SA - Arabia Saudita 7
VE - Venezuela 7
GP - Guadalupe 6
MA - Marocco 6
SC - Seychelles 6
SI - Slovenia 6
SV - El Salvador 6
TT - Trinidad e Tobago 6
PE - Perù 5
PR - Porto Rico 5
PT - Portogallo 5
SD - Sudan 5
TN - Tunisia 5
TW - Taiwan 5
HN - Honduras 4
JM - Giamaica 4
JO - Giordania 4
KZ - Kazakistan 4
NI - Nicaragua 4
NO - Norvegia 4
SY - Repubblica araba siriana 4
UZ - Uzbekistan 4
BY - Bielorussia 3
DZ - Algeria 3
EE - Estonia 3
EG - Egitto 3
HU - Ungheria 3
IR - Iran 3
LK - Sri Lanka 3
PY - Paraguay 3
RO - Romania 3
SN - Senegal 3
TH - Thailandia 3
UY - Uruguay 3
AL - Albania 2
AM - Armenia 2
BO - Bolivia 2
CW - ???statistics.table.value.countryCode.CW??? 2
DK - Danimarca 2
GE - Georgia 2
GR - Grecia 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LY - Libia 2
NA - Namibia 2
PA - Panama 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BJ - Benin 1
BM - Bermuda 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CU - Cuba 1
Totale 7.095
Città #
Ashburn 425
Santa Clara 365
Singapore 335
San Jose 237
Hefei 189
Council Bluffs 188
Hong Kong 180
Chandler 123
Milan 87
London 82
Fairfield 79
Beijing 73
Nyköping 71
Los Angeles 68
New York 65
Seoul 64
Rome 60
Ho Chi Minh City 58
Chicago 54
Munich 51
Bologna 43
Jakarta 42
Dallas 40
Hanoi 40
Cambridge 39
Modena 38
Seattle 37
Shanghai 34
Houston 32
Woodbridge 32
Lauterbourg 31
Wilmington 31
San Diego 30
Helsinki 29
The Dalles 27
Buffalo 25
Atlanta 22
Moscow 22
Naples 22
Parma 21
Frankfurt am Main 19
Toronto 19
Boardman 17
Montreal 17
Princeton 17
Orem 15
Salt Lake City 14
São Paulo 14
Ann Arbor 12
Brooklyn 12
Columbia 12
Florence 11
Hillsboro 11
Warsaw 11
Hamm 10
Kent 10
Sofia 10
Turku 10
Vienna 10
Ankara 9
Brno 9
Buenos Aires 9
Columbus 9
Lappeenranta 9
Madrid 9
Portsmouth 9
Brussels 8
Denver 8
Dublin 8
Düsseldorf 8
Haiphong 8
Mexico City 8
Miami 8
Phoenix 8
Tampa 8
Tokyo 8
Turin 8
Verona 8
Amsterdam 7
Baghdad 7
Bremen 7
Brighton 7
Hyderabad 7
Minneapolis 7
Murcia 7
Nuremberg 7
Poplar 7
Redondo Beach 7
San Francisco 7
Belo Horizonte 6
Bomporto 6
Cologne 6
Guangzhou 6
Guayaquil 6
Istanbul 6
Johannesburg 6
Mumbai 6
Newark 6
North Bergen 6
Paris 6
Totale 4.044
Nome #
Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality. 568
Herpes Simplex re-activation in patients with SARS-CoV2 pneumonia: a prospective observational study. 396
Incidence, risk factors and outcome of acute kidney injury (AKI) in patients with COVID-19 378
First and second waves among hospitalised patients with COVID-19 with severe pneumonia: a comparison of 28-day mortality over the 1-year pandemic in a tertiary university hospital in Italy 360
Management of Sepsis in the First 24 Hours: Bundles of Care and Individualized Approach 349
Adjunctive therapy with vitamin c and thiamine in patients treated with steroids for refractory septic shock: A propensity matched before-after, case-control study 335
Adjunctive Immunotherapy With Polyclonal Ig-M Enriched Immunoglobulins for Septic Shock: From Bench to Bedside. The Rationale for a Personalized Treatment Protocol 311
Effects of cytokine blocking agents on hospital mortality in patients admitted to ICU with acute respiratory distress syndrome by SARS-CoV2 infection: retrospective cohort study. 298
Advances and Challenges in Sepsis Management: Modern Tools and Future Directions 293
Ceftazidime/Avibactam in Ventilator-Associated Pneumonia Due to Difficult-to-Treat Non-Fermenter Gram-Negative Bacteria in COVID-19 Patients: A Case Series and Review of the Literature 265
Sex-related mortality differences in young adult septic shock patients 257
Long-Term Impact of the COVID-19 Pandemic on In-Hospital Antibiotic Consumption and Antibiotic Resistance: A Time Series Analysis (2015-2021) 249
The association of procalcitonin and C- reactive protein with bacterial infections acquired during ICU stay in COVID-19 critically ill patients. 244
Incidence and prognosis of ventilator-associated pneumonia in critically ill patients with covid-19: A multicenter study 237
Association Between Pulmonary Aspergillosis And Cytomegalovirus Reactivation In Critically Ill Covid-19 Patients: A Prospective Observational Cohort Study. 232
Association between respiratory distress time and invasive mechanical ventilation in COVID-19 patients: a multicentre regional cohort study. 223
Critical COVID-19 Patients Through First, Second And Third Wave: Retrospective Observational Study Comparing Outcomes In ICU. 219
Role of selective digestive decontamination in the prevention of VAP in COVID-19 patients: a pre-post observational study. 206
Oxygen: a powerful drug to handle with care 203
Rationale for polyclonal intravenous immunoglobulin adjunctive therapy in covid-19 patients: Report of a structured multidisciplinary consensus 194
Hospital-Acquired Infections in Critically Ill Patients With COVID-19 191
Perioperative Use of IgM-Enriched Immunoglobulins in Liver Transplantation Recipients at High Risk for Infections: A Preliminary Study 188
Difference in PaO2/FiO2 between high-flow nasal cannula and Venturi mask in hypoxemic COVID-19 patients 185
Adjunctive immunotherapeutic agents in patients with sepsis and septic shock: a multidisciplinary consensus of 23 175
Time course of risk factors associated with mortality of 1260 critically ill patients with COVID-19 admitted to 24 Italian intensive care units 175
The Interplay between Antibiotics and the Host Immune Response in Sepsis: From Basic Mechanisms to Clinical Considerations: A Comprehensive Narrative Review 136
The SIS NET ICU study: characteristics of patients with severe community acquired pneumonia admitted to Italian ICUs—a multicenter prospective observational study 56
Oxygenation improvement and duration of prone positioning are associated with ICU mortality in mechanically ventilated COVID-19 patients 52
Acquisition Origin Matters: Clinical, Microbiological and Immunological Characteristics and Treatment Effects in Community- vs. Hospital-Acquired Septic Shock 43
Angiotensin ii therapy in refractory septic shock: which patient can benefit most? A narrative review 39
Understanding, assessing and treating immune, endothelial and haemostasis dysfunctions in bacterial sepsis 37
The role of rapid and advanced microbiological methods in critical care: 2025 Emanuele Russo Delphi consensus 37
Protein C in adult patients with sepsis: from pathophysiology to monitoring and supplementation 29
Totale 7.160
Categoria #
all - tutte 31.106
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.106


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022304 0 0 0 0 12 16 47 28 49 20 63 69
2022/2023544 68 71 42 55 54 58 20 50 54 12 29 31
2023/2024523 16 23 43 49 83 47 47 41 15 31 46 82
2024/20251.587 51 39 53 124 263 241 125 92 190 88 149 172
2025/20262.698 261 163 217 291 335 114 330 144 259 265 214 105
2026/20271.271 121 503 165 427 55 0 0 0 0 0 0 0
Totale 7.160